CClinicalTrials.gg
Sign In
CompletedNCT07765407Updated Aug 14, 2026

A Clinical Trial to Evaluate the Effects of a Supplement on Supporting Signs of a Healthy Metabolism

An interventional study of Love Wellness Energize in Poor Energy Levels, Poor Metabolism and Difficulty With Weight Management, sponsored by Love Wellness. Completed at 1 site in United States. Open to participants aged 25 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Love Wellness · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
25 Years to 45 Years
Sex
All
01

Study summary

This study evaluates the effects of Love Wellness Energize, a dietary supplement, on supporting signs of a healthy metabolism in women aged 25-45 who report poor energy levels, perception of poor metabolism, difficulty with weight management, and feeling bloated. The trial is a single-arm, open-label, virtual study conducted over 4 weeks with 40 female participants.

Participants will dissolve one tablet of the test product in 16 fl.oz/475 mL of water twice daily and complete self-reported questionnaires at Baseline, Week 1, Week 2, Week 3, and Week 4. The primary endpoint is change in metabolism support, and secondary endpoints include perceptions of energy, bloating after hydration, and weight management support.

02

Conditions studied

  • Poor Energy Levels
  • Poor Metabolism
  • Difficulty With Weight Management
  • Bloating
03

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be female.
  • Be aged 25-45.
  • Currently experiencing issues regarding all of the following: poor energy levels, perception of poor metabolism, difficulty with weight management, and feeling bloated.
  • Generally healthy - does not live with any uncontrolled chronic disease.
  • Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
  • Willing to maintain their current diet, sleep schedule, and activity level for the study duration.
  • Resides in the United States.

Exclusion criteria

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
  • Anyone diagnosed with and getting treated for Parkinson's disease.
  • Anyone taking a prescription diabetes medication including but not limited to GLP-1 receptor agonist medications such as Ozempic, Wegovy, or Mounjaro.
  • Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone testing or planning to test, in the next 4 weeks, a product for another research study.
  • Anyone unwilling to follow the study protocol.
  • Anyone with any allergies or sensitivities to any of the study product ingredients.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Love Wellness Energize

    Dietary Supplement: Love Wellness Energize

Interventions

  • Dietary supplementLove Wellness Energize

    All participants dissolve one tablet of Love Wellness Energize in 16 fl.oz/475 mL of water twice daily at 11 am and 3 pm (or after planned exercise) for 4 weeks. Ingredients include Vitamin B1 15 mg, Vitamin B3 30 mg, Vitamin B6 10 mg, Vitamin B12 250 mcg, Calcium 100 mg, Magnesium 60 mg, Chromium 200 mcg, Sodium 310 mg, and Potassium 200 mg, among other excipients.

05

What researchers measure

Primary outcomes

  1. Change in Healthy Metabolism Support

    Self-reported perception of metabolism support, assessed via self-reported questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

Secondary outcomes

  1. Change in Self-Reported Energy

    Participants' perceived effects of the test product on energy levels, assessed via self-reported questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  2. Change in Self-Reported Bloating After Hydration

    Participants' perceived effects of the test product on bloating after hydration, assessed via self-reported questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  3. Change in Self-Reported Weight Management Support

    Participants' perceived effects of the test product on weight management support, assessed via self-reported questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

06

Study locations

1 site
  • Citruslabs
    Las Vegas, Nevada 89101, United States
07

Registry details

Key details

Study ID
NCT07765407
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Apr 8, 2025
Primary completion
May 29, 2025
Completion
May 29, 2025
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Love Wellness

Start the discussion